questionsmedicales.fr
Maladies de l'appareil respiratoire
Maladies pulmonaires
Bronchopneumopathies obstructives
Bronchopneumopathies obstructives : Questions médicales fréquentes
Diagnostic
5
Fonction pulmonaire
Tests de diffusion
Oxymétrie
Saturation en oxygène
Symptômes
5
Obstruction
Respiration difficile
Douleurs thoraciques
Toux chronique
Exacerbation
Expectorations
Stades de la maladie
Symptômes
Prévention
5
Vaccination
Infections respiratoires
Masques
Polluants de l'air
Éducation
Comportements sains
Contrôle de l'environnement
Irritants
Traitements
5
Bronchodilatateurs
Corticostéroïdes
Réhabilitation pulmonaire
Qualité de vie
Oxygénothérapie
Saturation en oxygène
Chirurgie
Réduction de volume pulmonaire
Complications
5
Insuffisance respiratoire
Infections pulmonaires
Maladies cardiaques
Hypoxie chronique
Qualité de vie
Activité physique
Exacerbations
Hospitalisation
Infections respiratoires
Patients BPCO
Facteurs de risque
5
Antécédents familiaux
Maladies pulmonaires
Exposition professionnelle
Produits chimiques
Tabagisme passif
Non-fumeurs
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Bronchopneumopathies obstructives : Questions médicales les plus fréquentes",
"headline": "Bronchopneumopathies obstructives : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Bronchopneumopathies obstructives : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-07",
"dateModified": "2026-02-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Bronchopneumopathies obstructives"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies pulmonaires",
"url": "https://questionsmedicales.fr/mesh/D008171",
"about": {
"@type": "MedicalCondition",
"name": "Maladies pulmonaires",
"code": {
"@type": "MedicalCode",
"code": "D008171",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C08.381"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Bronchiolite oblitérante",
"alternateName": "Bronchiolitis Obliterans",
"url": "https://questionsmedicales.fr/mesh/D001989",
"about": {
"@type": "MedicalCondition",
"name": "Bronchiolite oblitérante",
"code": {
"@type": "MedicalCode",
"code": "D001989",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C08.381.495.146.135.140"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Pneumonie organisée",
"alternateName": "Organizing Pneumonia",
"url": "https://questionsmedicales.fr/mesh/D000092124",
"about": {
"@type": "MedicalCondition",
"name": "Pneumonie organisée",
"code": {
"@type": "MedicalCode",
"code": "D000092124",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C08.381.495.146.135.140.600"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Pneumonie organisée cryptogénique",
"alternateName": "Cryptogenic Organizing Pneumonia",
"url": "https://questionsmedicales.fr/mesh/D018549",
"about": {
"@type": "MedicalCondition",
"name": "Pneumonie organisée cryptogénique",
"code": {
"@type": "MedicalCode",
"code": "D018549",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C08.381.495.146.135.140.600.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Pneumonie organisée cryptogénique",
"alternateName": "Cryptogenic Organizing Pneumonia",
"url": "https://questionsmedicales.fr/mesh/D018549",
"about": {
"@type": "MedicalCondition",
"name": "Pneumonie organisée cryptogénique",
"code": {
"@type": "MedicalCode",
"code": "D018549",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C08.381.495.146.135.140.600.750"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Bronchopneumopathies obstructives",
"alternateName": "Lung Diseases, Obstructive",
"code": {
"@type": "MedicalCode",
"code": "D008173",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Alison Morris",
"url": "https://questionsmedicales.fr/author/Alison%20Morris",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA; and."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Gerard J Criner",
"url": "https://questionsmedicales.fr/author/Gerard%20J%20Criner",
"affiliation": {
"@type": "Organization",
"name": "Temple University School of Medicine, Philadelphia, Pennsylvania."
}
},
{
"@type": "Person",
"name": "Marcus A Mall",
"url": "https://questionsmedicales.fr/author/Marcus%20A%20Mall",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatric Pulmonology, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany."
}
},
{
"@type": "Person",
"name": "Saima Saeed",
"url": "https://questionsmedicales.fr/author/Saima%20Saeed",
"affiliation": {
"@type": "Organization",
"name": "Dr. Saima Saeed, MRCP (Resp Med) (UK), MSc, The Indus Hospital & Health Network, Karachi, Pakistan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Similarities of metabolomic disturbances in prematurity-associated obstructive lung disease to chronic obstructive pulmonary disease.",
"datePublished": "2024-10-07",
"url": "https://questionsmedicales.fr/article/39375379",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-73704-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Obstructive Lung Disease Linked to Occupational Exposures in Malawian Tobacco Farmers.",
"datePublished": "2023-05-24",
"url": "https://questionsmedicales.fr/article/37194463",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/1059924X.2023.2215256"
}
},
{
"@type": "ScholarlyArticle",
"name": "Physiotherapy interventions on chest wall mobility in obstructive lung diseases: A systematic review.",
"datePublished": "2023-12-30",
"url": "https://questionsmedicales.fr/article/38763581",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jbmt.2023.11.046"
}
},
{
"@type": "ScholarlyArticle",
"name": "Peripheral airway dysfunction in prematurity-associated obstructive lung disease identified by oscillometry.",
"datePublished": "2023-09-13",
"url": "https://questionsmedicales.fr/article/37701982",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ppul.26658"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sex modifies the risk of HIV-associated obstructive lung disease in Ugandans postpneumonia.",
"datePublished": "2023-06-19",
"url": "https://questionsmedicales.fr/article/37352494",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/QAD.0000000000003626"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies de l'appareil respiratoire",
"item": "https://questionsmedicales.fr/mesh/D012140"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies pulmonaires",
"item": "https://questionsmedicales.fr/mesh/D008171"
},
{
"@type": "ListItem",
"position": 4,
"name": "Bronchopneumopathies obstructives",
"item": "https://questionsmedicales.fr/mesh/D008173"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Bronchopneumopathies obstructives - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Bronchopneumopathies obstructives",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-04-29",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Bronchopneumopathies obstructives",
"description": "Comment diagnostiquer une BPCO ?\nQuels tests sont utilisés pour évaluer la fonction pulmonaire ?\nQuels signes cliniques indiquent une obstruction ?\nQuand faire un scanner thoracique ?\nQuel rôle joue l'oxymétrie dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D008173#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Bronchopneumopathies obstructives",
"description": "Quels sont les symptômes principaux de la BPCO ?\nComment la BPCO affecte-t-elle la respiration ?\nLa BPCO cause-t-elle des douleurs thoraciques ?\nQuels signes indiquent une exacerbation ?\nLes symptômes de la BPCO varient-ils selon les stades ?",
"url": "https://questionsmedicales.fr/mesh/D008173#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Bronchopneumopathies obstructives",
"description": "Comment prévenir la BPCO ?\nQuel rôle joue la vaccination dans la prévention ?\nLes masques sont-ils utiles pour prévenir la BPCO ?\nComment l'éducation peut-elle aider à prévenir la BPCO ?\nLe contrôle de l'environnement est-il important ?",
"url": "https://questionsmedicales.fr/mesh/D008173#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Bronchopneumopathies obstructives",
"description": "Quels médicaments sont utilisés pour la BPCO ?\nComment la réhabilitation pulmonaire aide-t-elle ?\nQuand envisager une oxygénothérapie ?\nQuels sont les traitements non médicamenteux ?\nLa chirurgie est-elle une option pour la BPCO ?",
"url": "https://questionsmedicales.fr/mesh/D008173#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Bronchopneumopathies obstructives",
"description": "Quelles sont les complications possibles de la BPCO ?\nLa BPCO peut-elle entraîner des problèmes cardiaques ?\nComment la BPCO affecte-t-elle la qualité de vie ?\nLes exacerbations peuvent-elles être graves ?\nQuels sont les risques d'infections chez les patients BPCO ?",
"url": "https://questionsmedicales.fr/mesh/D008173#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Bronchopneumopathies obstructives",
"description": "Quels sont les principaux facteurs de risque de la BPCO ?\nL'âge influence-t-il le risque de BPCO ?\nLes antécédents familiaux jouent-ils un rôle ?\nL'exposition professionnelle est-elle un facteur de risque ?\nLe tabagisme passif est-il dangereux ?",
"url": "https://questionsmedicales.fr/mesh/D008173#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une BPCO ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique, la spirométrie et des radiographies thoraciques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la fonction pulmonaire ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "La spirométrie et les tests de diffusion des gaz sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une obstruction ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent la dyspnée, la toux chronique et la production de mucus."
}
},
{
"@type": "Question",
"name": "Quand faire un scanner thoracique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un scanner est recommandé si les résultats de la spirométrie sont anormaux ou ambigus."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'oxymétrie dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'oxymétrie mesure la saturation en oxygène et aide à évaluer la gravité de l'obstruction."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux de la BPCO ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la toux, la dyspnée, la fatigue et la respiration sifflante."
}
},
{
"@type": "Question",
"name": "Comment la BPCO affecte-t-elle la respiration ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle provoque une obstruction des voies respiratoires, rendant la respiration difficile."
}
},
{
"@type": "Question",
"name": "La BPCO cause-t-elle des douleurs thoraciques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs thoraciques peuvent survenir en raison de la toux chronique et de l'effort respiratoire."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une exacerbation ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une augmentation de la dyspnée, de la toux et des expectorations signale une exacerbation."
}
},
{
"@type": "Question",
"name": "Les symptômes de la BPCO varient-ils selon les stades ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes s'aggravent généralement avec la progression de la maladie."
}
},
{
"@type": "Question",
"name": "Comment prévenir la BPCO ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme, réduire l'exposition aux polluants et pratiquer une activité physique régulière."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la vaccination dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccins contre la grippe et le pneumocoque réduisent le risque d'infections respiratoires."
}
},
{
"@type": "Question",
"name": "Les masques sont-ils utiles pour prévenir la BPCO ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, porter un masque peut réduire l'exposition aux irritants et aux polluants de l'air."
}
},
{
"@type": "Question",
"name": "Comment l'éducation peut-elle aider à prévenir la BPCO ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation sensibilise aux risques et aux comportements sains pour protéger les poumons."
}
},
{
"@type": "Question",
"name": "Le contrôle de l'environnement est-il important ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, réduire les allergènes et les irritants dans l'environnement aide à prévenir la BPCO."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour la BPCO ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les bronchodilatateurs et les corticostéroïdes inhalés sont couramment prescrits."
}
},
{
"@type": "Question",
"name": "Comment la réhabilitation pulmonaire aide-t-elle ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle améliore la capacité pulmonaire et la qualité de vie par des exercices et des conseils."
}
},
{
"@type": "Question",
"name": "Quand envisager une oxygénothérapie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'oxygénothérapie est envisagée si la saturation en oxygène est inférieure à 88%."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements non médicamenteux ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent l'arrêt du tabac, la réhabilitation pulmonaire et l'éducation."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option pour la BPCO ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chirurgie peut être envisagée dans les cas graves, comme la réduction de volume pulmonaire."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la BPCO ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'insuffisance respiratoire, les infections pulmonaires et les maladies cardiaques."
}
},
{
"@type": "Question",
"name": "La BPCO peut-elle entraîner des problèmes cardiaques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la BPCO augmente le risque de maladies cardiaques en raison de l'hypoxie chronique."
}
},
{
"@type": "Question",
"name": "Comment la BPCO affecte-t-elle la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut réduire la qualité de vie en limitant l'activité physique et en provoquant des symptômes chroniques."
}
},
{
"@type": "Question",
"name": "Les exacerbations peuvent-elles être graves ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les exacerbations peuvent nécessiter une hospitalisation et entraîner des complications graves."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'infections chez les patients BPCO ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients BPCO sont plus susceptibles de développer des infections respiratoires et pulmonaires."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque de la BPCO ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, l'exposition à la pollution et les antécédents familiaux sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de BPCO ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout chez les fumeurs et les personnes exposées à des irritants."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies pulmonaires augmentent le risque de BPCO."
}
},
{
"@type": "Question",
"name": "L'exposition professionnelle est-elle un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les travailleurs exposés à des poussières et des produits chimiques ont un risque accru."
}
},
{
"@type": "Question",
"name": "Le tabagisme passif est-il dangereux ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme passif augmente le risque de développer une BPCO chez les non-fumeurs."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 27/02/2026
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA; and.
Publications dans "Bronchopneumopathies obstructives" :
3 publications dans cette catégorie
Publications dans "Bronchopneumopathies obstructives" :
3 publications dans cette catégorie
Affiliations :
Temple University School of Medicine, Philadelphia, Pennsylvania.
Publications dans "Bronchopneumopathies obstructives" :
3 publications dans cette catégorie
Affiliations :
Department of Pediatric Pulmonology, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Berlin Institute of Health, Berlin, Germany.
German Center for Lung Research, Berlin, Germany.
Publications dans "Bronchopneumopathies obstructives" :
2 publications dans cette catégorie
Affiliations :
Dr. Saima Saeed, MRCP (Resp Med) (UK), MSc, The Indus Hospital & Health Network, Karachi, Pakistan.
Publications dans "Bronchopneumopathies obstructives" :
2 publications dans cette catégorie
Affiliations :
Dr. Madiha Siddiqui (FCPS, Pulmonology), The Indus Hospital & Health Network, Karachi, Pakistan.
Publications dans "Bronchopneumopathies obstructives" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Minneapolis VA Health Care System, Minneapolis, MN.
Department of Medicine, University of Minnesota, Minneapolis, MN.
Publications dans "Bronchopneumopathies obstructives" :
2 publications dans cette catégorie
Affiliations :
Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN.
Publications dans "Bronchopneumopathies obstructives" :
2 publications dans cette catégorie
Affiliations :
Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN.
Publications dans "Bronchopneumopathies obstructives" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN.
Publications dans "Bronchopneumopathies obstructives" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, University of British Columbia, Vancouver.
Publications dans "Bronchopneumopathies obstructives" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Minneapolis VA Health Care System, Minneapolis, MN.
Department of Medicine, University of Minnesota, Minneapolis, MN.
Publications dans "Bronchopneumopathies obstructives" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN.
Publications dans "Bronchopneumopathies obstructives" :
2 publications dans cette catégorie
Affiliations :
Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Publications dans "Bronchopneumopathies obstructives" :
2 publications dans cette catégorie
Publications dans "Bronchopneumopathies obstructives" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Publications dans "Bronchopneumopathies obstructives" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Publications dans "Bronchopneumopathies obstructives" :
2 publications dans cette catégorie
Affiliations :
Division of Respiratory Medicine, Department of Medicine, Kingston Health Science Center, Queen's University, Richardson House, 102 Stuart Street, Kingston, Ontario K7L 2V6, Canada.
Publications dans "Bronchopneumopathies obstructives" :
2 publications dans cette catégorie
Affiliations :
National Heart and Lung Institute, Imperial College London, London, UK.
Publications dans "Bronchopneumopathies obstructives" :
2 publications dans cette catégorie
Affiliations :
Liverpool School of Tropical Medicine, Liverpool, UK.
Publications dans "Bronchopneumopathies obstructives" :
Prematurity-associated lung disease (PLD) is a long-term consequence of preterm-birth. Since the underlying mechanisms of PLD remain poorly characterised, we compared the urinary metabolome between re...
Nicotine and pesticide exposure in agricultural settings have been linked to the development of chronic respiratory disease in workers. However, this has not been extensively studied in Africa. The ai...
The aim of this systematic review was to investigate the effectiveness of physiotherapy interventions on chest mobility in obstructive lung diseases....
Searches were performed in PEDro, Pubmed and Cochrane Central Register of Controlled Trials databases without language restrictions between 2010 and 25th December 2020. Randomized controlled trials (R...
Five studies included had good to excellent quality. A total of 139 patients were included in all RCTs. Intervention duration ranged from a single session to 12 weeks and the intervention schedules va...
The result of this first systematic review that investigates the effects of physiotherapy interventions on chest wall mobility in obstructive lung diseases suggests that more and better quality RCTs w...
Mechanisms underlying lung dysfunction after preterm birth are poorly understood. Studying phenotypes of prematurity-associated lung disease may aid understanding of underlying mechanisms. Preterm-bor...
Preterm-born children, born at gestation of 34 weeks or less, were classified into those with prematurity-associated obstructive lung disease (POLD; FEV...
From 241 participants aged 7-12 years, complete data were available from 179: 15 children with POLD and 11 with pPRISm were compared with 93 preterm and 60 term controls. POLD group, when compared to ...
Preterm-born children with obstructive airway disease had the greatest oscillometry impairments and the largest improvements after postexercise bronchodilator compared to control groups. Oscillometry ...
Spirometric abnormalities are frequent, and obstructive lung disease (OLD) is a common comorbidity among people with HIV (PWH). HIV increases the risk of many comorbidities to a greater degree in wome...
To evaluate the associations between sex and HIV with abnormal lung function, women and men with and without HIV underwent spirometric testing after completing therapy for pneumonia, including tubercu...
Among 348 participants, 147 (42%) were women and 135 (39%) were HIV-positive. Sixteen (11%) women and 23 men (11%) had OLD. The HIV-sex interaction was significant for obstructive lung disease ( P = 0...
HIV appears to increase the risk of OLD to a greater degree in women than in men in an urban Ugandan setting. The mechanistic explanation for this interaction by sex remains unclear and warrants furth...
Spirometric small airways obstruction (SAO) is common in the general population. Whether spirometric SAO is associated with respiratory symptoms, cardiometabolic diseases, and quality of life (QoL) is...
Using data from the Burden of Obstructive Lung Disease study (N = 21,594), we defined spirometric SAO as the mean forced expiratory flow rate between 25 and 75% of the FVC (FEF...
Almost a fifth of the participants had spirometric SAO (19% for FEF...
Spirometric SAO is associated with respiratory symptoms, cardiovascular disease, and QoL. Consideration should be given to the measurement of FEF...
There is no clear consensus as to what constitutes an obstructive ventilatory impairment (OVI) in pediatric populations....
To determine the percentage of children/adolescents having an OVI among those addressed for spirometry after taking into account the definitions advanced by some international scholarly societies [Bri...
This bi-centric cross-sectional study involves two medical structures in Sousse/Tunisia, and will encompass children/adolescents aged 6-18 years. A medical questionnaire will be administered, clinical...
The percentage of children/adolescents having an OVI will significantly vary between the six definitions....
The frequency of OVI in a pediatric population will depend on the definition chosen....
To understand the prevalence rate of obstructive pulmonary dysfunction in workers exposed to silica dust and analyze its risk factors, so as to provide reference for the formulation of diagnostic crit...
Data collection and structured questionnaire were used to collect the data of 2064 workers exposed to silica dust who underwent health examination in Hunan Occupational Disease Prevention and Control ...
The prevalence rate of obstructive pulmonary ventilation dysfunction (FEV1/FVC < 70%) was 2.3% in 2064 silica dust exposed workers. The prevalence of restrictive pulmonary ventilation dysfunction (FVC...
Silica dust exposure can cause obstructive pulmonary ventilation dysfunction and lead to chronic obstructive pulmonary disease. High level of exposure is a risk factor for obstructive pulmonary ventil...
Muco-obstructive lung disease is a new classification under the diseases of respiratory tract. A lot of discussion is still going on regarding this new group of diseases. It is characterised by obstru...
Chronic obstructive pulmonary disease (COPD) carries a high burden of morbidity and mortality to patient and a high cost to health care systems. Lung transplantation is a last resort available for end...